European Economic Community
Guiding principles for industrial policy in the pharmaceutical sector of the European Community. European Economic Community
Abstract
The aim of this work is to present the guidelines suggested by the E. Community for an industrial policy concerning the Pharmaceutical sector, within the framework of a common plan encompassing health, industrial growth and employment. In addition, as there are signs of structural difficulties in the pharmaceutical industries of the Community which are yielding ground in comparison with their main worldwide competitors, suggestions are made for a reversal of this trend. Larger financial support is needed for research and development (RD) of new therapeutically innovative medicines, which is a condition for its long term competitiveness, and a stricter prices control by the Community over national regulations is also strongly advised.
Source and rights
Published by Bollettino chimico farmaceutico, 1996. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Organisation
- European Economic Community
- Published
- 1996
- Country of origin
- 🌐 International
- Scope
- Regional
- Journal
- Bollettino chimico farmaceutico
- PubMed
- 9081293
- Added to Prognia
- 24 July 2026
More in other
- The Canine Cognitive Dysfunction Syndrome Working Group guidelines for diagnosis and monitoring of canine cognitive dysfunction syndromeEuropean Respiratory Society · 2026
- Chinese guidelines for the clinical application of antibacterial drugs for febrile neutropenia (2026)Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2026
